GM Advisory Group LLC Has $1.87 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

GM Advisory Group LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,213 shares of the medical equipment provider’s stock after buying an additional 141 shares during the period. GM Advisory Group LLC’s holdings in Intuitive Surgical were worth $1,874,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also made changes to their positions in the company. Trust Investment Advisors bought a new stake in shares of Intuitive Surgical during the 2nd quarter valued at $215,000. Ieq Capital LLC raised its stake in Intuitive Surgical by 10.7% in the second quarter. Ieq Capital LLC now owns 27,040 shares of the medical equipment provider’s stock valued at $12,029,000 after purchasing an additional 2,616 shares in the last quarter. Intech Investment Management LLC lifted its position in Intuitive Surgical by 6.2% during the second quarter. Intech Investment Management LLC now owns 21,279 shares of the medical equipment provider’s stock worth $9,466,000 after purchasing an additional 1,244 shares during the period. Mark Sheptoff Financial Planning LLC acquired a new stake in Intuitive Surgical during the second quarter worth about $37,000. Finally, Sienna Gestion increased its holdings in Intuitive Surgical by 5.3% in the 2nd quarter. Sienna Gestion now owns 17,036 shares of the medical equipment provider’s stock valued at $7,575,000 after buying an additional 853 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of recent analyst reports. Truist Financial upped their price target on shares of Intuitive Surgical from $450.00 to $515.00 and gave the stock a “buy” rating in a report on Tuesday, July 16th. Piper Sandler raised their target price on Intuitive Surgical from $490.00 to $495.00 and gave the company an “overweight” rating in a report on Friday, July 19th. The Goldman Sachs Group assumed coverage on Intuitive Surgical in a report on Thursday, May 30th. They set a “buy” rating and a $500.00 price target for the company. Barclays upped their price objective on Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research report on Thursday, July 18th. Finally, Robert W. Baird boosted their target price on Intuitive Surgical from $487.00 to $503.00 and gave the stock an “outperform” rating in a research note on Friday, July 19th. Six equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $446.45.

Insider Transactions at Intuitive Surgical

In related news, Director Craig H. Barratt sold 1,400 shares of Intuitive Surgical stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total transaction of $641,382.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $446.60, for a total transaction of $167,921.60. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,458,979.60. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Craig H. Barratt sold 1,400 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total value of $641,382.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 53,120 shares of company stock worth $25,528,753. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Up 1.6 %

NASDAQ ISRG opened at $490.01 on Friday. The company has a market capitalization of $173.81 billion, a price-to-earnings ratio of 88.45, a PEG ratio of 5.41 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $254.85 and a twelve month high of $496.18. The stock has a fifty day simple moving average of $467.17 and a 200 day simple moving average of $424.26.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The company had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. During the same period in the previous year, the firm earned $1.18 earnings per share. The firm’s quarterly revenue was up 14.5% on a year-over-year basis. Research analysts expect that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.